EuroEspes Biotechnology (Ebiotec) is the Biotechnology Centre of the EuroEspes Group, where basic research is carried out and exclusive nutraceutical bioproducts are manufactured. All of Ebiotec’s nutraceuticals are supported by preclinical and clinical scientific documentation, are prophylactically oriented, and have a high therapeutic value as adjuvant therapy in various health problems (lipid metabolism, neurodegenerative problems, cardiovascular and cerebrovascular disorders, immune system dysfunction, neoplastic processes). Among our priorities is the search for efficient solutions to the serious problem posed by dementia, stroke, and other degenerative pathologies of the nervous system, such as Parkinson’s disease.
Business areas:
Biomedical Research Centre / EuroEspes Biotechnology (Ebiotec) / EuroEspes Publishing.
Business lines:
Research, development, and manufacture of nutraceutical bioproducts.
Genomic medicine, pharmacogenomics, and dissemination of scientific knowledge in the field of genomic medicine.